ConductScience.org, home

Paper · 7528126

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14058743Patterns of seizure activation after withdrawal of antiepileptic medication.Neurology1985https://conductscience.org/library/papers/4058743PubMed
21868824The development of a seizure severity scale as an outcome measure in epilepsy.Epilepsy Res1991https://conductscience.org/library/papers/1868824PubMed
34214695The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study.Epilepsia1974https://conductscience.org/library/papers/4214695PubMed
42739918Phenytoin withdrawal and seizure frequency.Neurology1989https://conductscience.org/library/papers/2739918PubMed
53925335Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.N Engl J Med1985https://conductscience.org/library/papers/3925335PubMed
61971862Gabapentin in partial epilepsy. UK Gabapentin Study Group.Lancet1990https://conductscience.org/library/papers/1971862PubMed
71416808Felbamate monotherapy: controlled trial in patients with partial onset seizures.Ann Neurol1992https://conductscience.org/library/papers/1416808PubMed
82044501Felbamate: a clinical trial for complex partial seizures.Epilepsia1991https://conductscience.org/library/papers/2044501PubMed
93922282gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy.Ann Neurol1985https://conductscience.org/library/papers/3922282PubMed
106141335Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy.Lancet1984https://conductscience.org/library/papers/6141335PubMed
11326542Valproate sodium: a controlled clinical trial including monitoring of drug levels.Epilepsia1977https://conductscience.org/library/papers/326542PubMed
128453943Outcomes of add-on treatment with lamotrigine in partial epilepsy.Epilepsia1993https://conductscience.org/library/papers/8453943PubMed
138251092Alternative analyses for antiepileptic drug trials.Epilepsy Res Suppl1993https://conductscience.org/library/papers/8251092PubMed
142282474Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis.Brain Res1990https://conductscience.org/library/papers/2282474PubMed
152508534Mossy fiber synaptic reorganization in the epileptic human temporal lobe.Ann Neurol1989https://conductscience.org/library/papers/2508534PubMed
168347179Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).N Engl J Med1993https://conductscience.org/library/papers/8347179PubMed
178469323Felbamate monotherapy for partial-onset seizures: an active-control trial.Neurology1993https://conductscience.org/library/papers/8469323PubMed
182645120A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.Epilepsy Res1989https://conductscience.org/library/papers/2645120PubMed
193391153Felbamate increases phenytoin but decreases carbamazepine concentrations.Epilepsia1988https://conductscience.org/library/papers/3391153PubMed
203527121Comparison of alternative outcome measures for antiepileptic drug trials.Arch Neurol1986https://conductscience.org/library/papers/3527121PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/7528126/references